DOXIMITY INC-CLASS A (DOCS) Stock Overview
NYSE:DOCS - US26622P1075 - Common Stock
DOCS Key Statistics, Chart & Performance
The current stock price of DOCS is 70.26 USD. In the past month the price increased by 9.75%. In the past year, price increased by 78.69%.
DOCS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 37.51 | 45.67B | ||
| WAY | WAYSTAR HOLDING CORP | 34.55 | 6.68B | ||
| HTFL | HEARTFLOW INC | N/A | 2.76B | ||
| CERT | CERTARA INC | 22.29 | 1.75B | ||
| PHR | PHREESIA INC | N/A | 1.52B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 12.06 | 1.47B | ||
| SDGR | SCHRODINGER INC | N/A | 1.38B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.37B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 1.09B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| CTEV | CLARITEV CORP | N/A | 1.02B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 917.97M |
Related stock screener links
About DOCS
Company Profile
Doximity, Inc. engages in the development and operation of an online platform for medical professionals. The company is headquartered in San Francisco, California and currently employs 830 full-time employees. The company went IPO on 2021-06-24. The company offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.
Company Info
DOXIMITY INC-CLASS A
500 Third Street, Suite 510
San Francisco CALIFORNIA US
CEO: Jeffrey Tangney
Employees: 830
Phone: 16505494330
DOXIMITY INC-CLASS A / DOCS FAQ
What is the stock price of DOXIMITY INC-CLASS A today?
The current stock price of DOCS is 70.26 USD. The price increased by 1.83% in the last trading session.
What is the ticker symbol for DOXIMITY INC-CLASS A stock?
The exchange symbol of DOXIMITY INC-CLASS A is DOCS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is DOCS stock listed?
DOCS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for DOXIMITY INC-CLASS A stock?
26 analysts have analysed DOCS and the average price target is 69.7 USD. This implies a price decrease of -0.8% is expected in the next year compared to the current price of 70.26. Check the DOXIMITY INC-CLASS A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DOXIMITY INC-CLASS A worth?
DOXIMITY INC-CLASS A (DOCS) has a market capitalization of 13.16B USD. This makes DOCS a Large Cap stock.
How many employees does DOXIMITY INC-CLASS A have?
DOXIMITY INC-CLASS A (DOCS) currently has 830 employees.
What are the support and resistance levels for DOXIMITY INC-CLASS A (DOCS) stock?
DOXIMITY INC-CLASS A (DOCS) has a support level at 67.15. Check the full technical report for a detailed analysis of DOCS support and resistance levels.
Is DOXIMITY INC-CLASS A (DOCS) expected to grow?
The Revenue of DOXIMITY INC-CLASS A (DOCS) is expected to grow by 12.02% in the next year. Check the estimates tab for more information on the DOCS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DOXIMITY INC-CLASS A (DOCS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DOCS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DOCS, evaluating the profitability, health, valuation and growth aspects
- DOXIMITY INC-CLASS A (DOCS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DOXIMITY INC-CLASS A (DOCS) Sales and EPS estimates to see what analysts future expectations are.
- DOXIMITY INC-CLASS A (DOCS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DOXIMITY INC-CLASS A (DOCS) Insider and Institutional Ownership to learn about the owners and their transactions.
- DOXIMITY INC-CLASS A (DOCS) Stock Chart to make your own analysis
- DOXIMITY INC-CLASS A (DOCS) Latest news and press-releases to stay up to date.
Does DOXIMITY INC-CLASS A (DOCS) stock pay dividends?
DOCS does not pay a dividend.
When does DOXIMITY INC-CLASS A (DOCS) report earnings?
DOXIMITY INC-CLASS A (DOCS) will report earnings on 2025-11-05, after the market close.
What is the Price/Earnings (PE) ratio of DOXIMITY INC-CLASS A (DOCS)?
The PE ratio for DOXIMITY INC-CLASS A (DOCS) is 47.15. This is based on the reported non-GAAP earnings per share of 1.49 and the current share price of 70.26 USD. Check the full fundamental report for a full analysis of the valuation metrics for DOCS.
What is the Short Interest ratio of DOXIMITY INC-CLASS A (DOCS) stock?
The outstanding short interest for DOXIMITY INC-CLASS A (DOCS) is 3.27% of its float. Check the ownership tab for more information on the DOCS short interest.
DOCS Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to DOCS. When comparing the yearly performance of all stocks, DOCS is one of the better performing stocks in the market, outperforming 91.59% of all stocks.
DOCS Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to DOCS. Both the health and profitability get an excellent rating, making DOCS a very profitable company, without any liquidiy or solvency issues.
DOCS Financial Highlights
Over the last trailing twelve months DOCS reported a non-GAAP Earnings per Share(EPS) of 1.49. The EPS increased by 43.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 39.88% | ||
| ROA | 19.52% | ||
| ROE | 22.93% | ||
| Debt/Equity | 0 |
DOCS Forecast & Estimates
26 analysts have analysed DOCS and the average price target is 69.7 USD. This implies a price decrease of -0.8% is expected in the next year compared to the current price of 70.26.
For the next year, analysts expect an EPS growth of 9.92% and a revenue growth 12.02% for DOCS